13D/13G Filings - KKR Phorm Investors L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-06-20
4:30 pm
Sale
2024-06-2013DTransphorm, Inc.
TGAN
KKR Phorm Investors L.P.0
0.000%
-24,724,468decrease
(Position Closed)
Filing
History
2024-01-11
4:40 pm
Unchanged
2024-01-1013DTransphorm, Inc.
TGAN
KKR Phorm Investors L.P.24,724,468
39.700%
0
(Unchanged)
Filing
History
2023-07-25
4:19 pm
Purchase
2023-07-2113DTransphorm, Inc.
TGAN
KKR Phorm Investors L.P.24,724,468
39.800%
1,735,988increase
(+7.55%)
Filing
History
2022-06-03
4:30 pm
Purchase
2022-06-0113DTransphorm, Inc.
TGAN
KKR Phorm Investors L.P.22,988,480
40.400%
22,988,480increase
(New Position)
Filing
History
2021-11-08
06:15 am
Purchase
2021-11-0513DTransphorm, Inc.
TGAN
KKR Phorm Investors L.P.22,988,480
45.800%
1,812,500increase
(+8.56%)
Filing
2020-07-21
4:45 pm
Unchanged
2020-07-1313DTransphorm, Inc.
TGAN
KKR Phorm Investors L.P.21,175,980
60.300%
0
(Unchanged)
Filing
2020-03-13
5:01 pm
Purchase
2020-02-1213DTransphorm, Inc.
TGAN
KKR Phorm Investors L.P.21,175,980
60.200%
21,175,980increase
(New Position)
Filing